These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3414733)

  • 1. Evaluation of a simple method for measuring blood cholesterol levels using non-laboratory observers.
    Pearson JR; Dusenbury LJ; Bakes-Martin R; Loverde M; Johnson J; Byyny RL
    Am J Med; 1988 Sep; 85(3):369-74. PubMed ID: 3414733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method.
    Nauck M; Rifai N
    Clin Chim Acta; 2000 Apr; 294(1-2):77-92. PubMed ID: 10727675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.
    Wong ND; Kawakubo M; LaBree L; Azen SP; Xiang M; Detrano R
    Am J Cardiol; 2004 Aug; 94(4):431-6. PubMed ID: 15325924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China.
    Wang C; Kong L; Yang Y; Wei Y; Zhu W; Su R; Lin L; Yang H
    Lipids Health Dis; 2018 Oct; 17(1):246. PubMed ID: 30382875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
    N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit of near patient cholesterol testing in occupational health clinics.
    Majeed FA; Turner HJ; Stuart JM; Cooper RD; Laite PA
    Occup Med (Lond); 1993 Feb; 43(1):23-6. PubMed ID: 8422442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypercholesterolemia and control with therapy].
    von Eckardstein A
    Praxis (Bern 1994); 2007 Apr; 96(15):583. PubMed ID: 17506387
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Chemcard cholesterol test and laboratory cholesterol measurements.
    Gan IE; Schier GM
    Aust N Z J Med; 1995 Dec; 25(6):716-9. PubMed ID: 8770337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Findings or disease--lipid metabolism with reference to the heart].
    Wolfram G
    Internist (Berl); 1986 Mar; 27(3):158-65. PubMed ID: 3519502
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
    Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved.
    Costanza MC; Wolff H; James RW; Morabia A
    J Clin Epidemiol; 2005 Aug; 58(8):841-8. PubMed ID: 16086475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
    Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
    Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula.
    Türkalp I; Cil Z; Ozkazanç D
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):13-7. PubMed ID: 15755695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.